Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07276776 · ClinicalTrials.gov registry record · NA

An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes

A NA study of Type 2 Diabetes Mellitus, sponsored by Insulet Corporation.

Active
Registry status
NA
Development phase
40
Enrollment target
6
Study locations

NCT07276776 is a NA study of Type 2 Diabetes Mellitus that is active but no longer recruiting, run by Insulet Corporation. The registered enrollment target is 40 participants, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 6 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07276776, a NA study of Type 2 Diabetes Mellitus, is active but no longer recruiting, sponsored by Insulet Corporation.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
6
Study locations

Study Summary

This is a single arm feasibility study to evaluate the Omnipod M System in adults with Type 2 Diabetes with the aim to enroll to 40 participants aged 18-75 years with type 2 diabetes to have a minimum of 20 participants initiate the use of Omnipod M System and the goal of 16 participants completing the 6-week treatment period.

Conditions Studied

Type 2 Diabetes Mellitus

Interventions

  • DEVICE Omnipod M system

Study Locations (6)

Massachusetts

  • Joslin Diabetes - Boston
  • MassResearch LLC. - Waltham

Texas

  • Texas Diabetes and Endocrinology (TDE) - Austin
  • Disease & Glandular Disease Clinic - San Antonio

Michigan

  • Henry Ford Health - Detroit

North Carolina

  • Mountain Area Health Educational Center ( MAHEC) - Asheville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-12-12
Est. Completion 2026-02-27
Phase NA

Sponsor

Insulet Corporation

16 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07276776

The ClinicalTrials.gov registry entry for NCT07276776 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The listed sponsor is Insulet Corporation, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Omnipod M system is the first listed.

NCT07276776 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Massachusetts, Texas, Michigan.

Frequently Asked Questions

What is clinical trial NCT07276776 about?

NCT07276776 is a clinical study titled "An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes". This is a single arm feasibility study to evaluate the Omnipod M System in adults with Type 2 Diabetes with the aim to enroll to 40 participants aged 18-75 years with type 2 diabetes to have a minimum of 20 participants initiate the use of Omnipod M System and the goal of 16 participants completing ...

What is the current status of trial NCT07276776?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-12-12. Estimated completion is 2026-02-27.

What conditions does trial NCT07276776 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT07276776?

The interventions under investigation include: Omnipod M system (DEVICE).

Who is sponsoring clinical trial NCT07276776?

This trial is sponsored by Insulet Corporation, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07276776 being conducted?

This trial has 6 study locations across Massachusetts, Michigan, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes Mellitus

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.